Andere talen Takara Bio Inc.

Aandelen

4974

JP3460200003

Vertraagde tijd Japan Exchange Andere beurzen 03:37:24 13-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.038 ^JPY	+1,27%		+2,27%	-17,25%

15/02	Takara Bio's toerekenbare inkomen daalt met 98,9% in fiscale negen maanden	MT
2023	Takara Bio Inc. Herziet de geconsolideerde winstverwachting voor het jaar dat eindigt op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024	10/05
Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery	03/04
Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	18/03
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024	22/02
Takara Bio's Attributable Income Falls 98.9% in Fiscal Nine Months	15/02
Takara Bio's first-to-market large-scale single-cell NGS profiling technologies poised to revolutionize biomarker discovery	06/02
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12
Takara Bio USA wins EU opposition hearing, revoking Jumpcode Genomics NGS library enrichment patent	12/12
Takara Bio Inc. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	09/11
Takara Bio : Annual Report 2023	13-09-23
Takara Bio : Financial Results Presentation (May 16, 2023)	29-05-23
Takara Bio : Notice of the 21th Annual General Meeting of Shareholders	23-05-23
Takara Bio : Consolidated Financial Statements for FY Ended March 31 2023	11-05-23
Takara Bio Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	11-05-23
Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023	09-02-23
Takara Bio Inc. Revised Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	09-02-23
Takara Bio : Financial Results Presentation (November 15, 2022)	25-11-22
Takara Bio : Consolidated Financial Statements for the Second Quarter Ended September 30, 2022	10-11-22
Takara Bio Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	10-11-22
Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023	10-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Takara Bio Inc.

Aandelen

4974

JP3460200003

Andere talen

Filters